Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
General Information Job Advert Title: 【つくば】分析開発サイエンティスト・外部製造技術統括（SME） Location: Tokodai, Ibaraki Division: External Manufacturing Employment Class: Permanent Description Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies
General Information Job Advert Title: Senior Scientist（Biology PJ lead） Location: Tsukuba,Ibaraki Division: Cell and Gene Therapy Research Employment Class: Permanent Description 【About Astellas】 Astellas is a global life sciences company committed to turning innovative science into
General Information Job Advert Title: Senior Scientist, Applied Safety JP, Applied Safety Location: Tsukuba, Ibaraki Division: Early Development and Translational Science Employment Class: Permanent Description 【About Astellas】 Astellas is a global life sciences company committed to
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Job Description SummaryDrive regulatory submission excellence and early-stage development strategy by authoring high-quality Japanese New Drug Applications and providing pharmacology or toxicology expertise to clinical programs in Japan. Job Description 職務内容 非臨床安全性担当者としてプロジェクトチームに参画しチームメンバーと協働し開発を推進する。 Globalメンバーの一員として，国内外の開発に非臨床安全性担当者として貢献する。 主な役割責任 早期化合物の安全性評価を行いチームへ適切に評価内容を伝える。 承認申請資料を作成し，当局からの照会回答を含む承認申請全般に責任をもつ。
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)